ImmuCell CorporationICCCNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-12.2%
5Y CAGR-6.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-12.2%/yr
vs +6.3%/yr prior
5Y CAGR
-6.9%/yr
Recent deceleration
Acceleration
-18.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.04M | -22.0% |
| 2024 | $3.90M | -11.3% |
| 2023 | $4.39M | -2.2% |
| 2022 | $4.49M | +7.8% |
| 2021 | $4.17M | -4.3% |
| 2020 | $4.35M | +18.1% |
| 2019 | $3.69M | +4.9% |
| 2018 | $3.52M | +71.8% |
| 2017 | $2.05M | +64.5% |
| 2016 | $1.24M | - |